📰 Alpmy News
Alpmy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alpmy. Real-time updates on events, politics, business and more.
February 15, 2024
Shares of Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $11.66 and traded as low as $10.77. Astellas Pharma shares last traded at $10.82, with a volume of 182,653 shares changing hands. Astellas Pharma Price Performance […]
January 11, 2024
Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 159,100 shares, an increase of 305.9% from the December 15th total of 39,200 shares. Based on an average trading volume of 554,500 shares, […]
January 4, 2024
International equities yield more and cost less on average than U.S. stocks. Legrand, RELX, and Astellas Pharma are among the current prospects.
December 15, 2023
By Ben Glickman Merck & Co., Pfizer and Astellas Pharma have received approval from the U.S. Food and Drug Administration for using Keytruda in...
November 14, 2023
Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) shares reached a new 52-week low on Monday . The stock traded as low as $11.25 and last traded at $11.57, with a volume of 586209 shares trading hands. The stock had previously closed at $11.78. Analysts Set New Price Targets Separately, Jefferies Financial Group cut Astellas […]
November 8, 2023
Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) reached a new 52-week low on Tuesday . The stock traded as low as $11.63 and last traded at $11.83, with a volume of 227767 shares changing hands. The stock had previously closed at $11.82. Analysts Set New Price Targets Separately, Jefferies Financial Group downgraded Astellas Pharma […]
October 25, 2023
Pharmaceutical stocks have generally fallen, partly because of regulatory concerns, but also because high interest rates have made the companies dividends...
October 19, 2023
Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) shares reached a new 52-week low during trading on Thursday . The stock traded as low as $12.45 and last traded at $12.47, with a volume of 411433 shares. The stock had previously closed at $12.66. Analysts Set New Price Targets Separately, Jefferies Financial Group downgraded Astellas […]
October 13, 2023
Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) saw a large decrease in short interest during the month of September. As of September 30th, there was short interest totalling 5,100 shares, a decrease of 54.1% from the September 15th total of 11,100 shares. Based on an average daily volume of 213,800 shares, the short-interest ratio […]
September 19, 2023
Apellis Pharmaceuticals Inc. shares jumped 8% premarket on Tuesday after competitor Iveric Bio, a unit of Astellas Pharma Inc. on Monday released results of...